SPX -0.62% VIX 6.80%
FED'S ROSENGREN SAYS ECONOMY DOESN'T LOOK LIKE IT NEEDS INTEREST-RATE CUT 
U.S. STOCKS END LOWER AS EXPECTATIONS FOR HALF-POINT RATE CUT WANE 
STOCKS HAVE TURNED NEGATIVE IN THE FINAL HOUR OF TRADING FRIDAY 
DISNEY'S LIVE-ACTION 'LION KING' SHOULD RULE THE MOVIE WORLD ON THIS HOT WEEKEND 
YOU CAN NOW BUY TRUMP-BRANDED STRAWS TO COUNTER THE 'LIBERAL' PAPER VERSIONS 
DEEP DIVE: BIG-BANK EARNINGS POINT TO NEAR-TERM PAIN AND LONG-TERM OPPORTUNITY 
CONSUMERS REMAIN UPBEAT ABOUT U.S. ECONOMY, UNIV. OF MICH. DATA SHOW 
'RELIEF' RALLY IN BOEING A KEY FACTOR IN KEEPING DOW IN POSITIVE TERRITORY 
RED ROBIN SHARES SOAR AFTER ACTIVIST-INVESTOR OFFER 
MICROSOFT HITS ALL-TIME INTRADAY HIGH AS IT JOINS BOEING IN PACING DOW ADVANCE 
Sun, Jul 21 11:28pm

Compare VRTX



Vertex Pharmaceuticals Inc [VRTX]
$174.13 3.96 (2.22%)

VRTX Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 45.33 Billion
VRTX Description

Vertex Pharmaceuticals discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, and Symdeko for cystic fibrosis, in addition to several pipeline candidates targeting this market. Vertex's pipeline also includes therapies for cancer, pain, inflammatory diseases, influenza, and other rare diseases.


Visit Website

VRTX Earnings

EPS 1.05 P/E Ratio 20.79
Previous Earnings Tue, Apr 30, 2019
Latest Earnings Wed, Jul 31, 2019 (In 10 days)

VRTX Dividend

Yield --
Ex-Date --
Pay Date --
History --

VRTX Charts

$151.80
52 Week Range
$194.78
Dec 24, 2018
Jan 18, 2019



Symbol Price Day % YTD %
VRTX $174.13 -2.22% 6.13%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy